【24h】

Development of NLCs for topical ATRAs applications

机译:主题atras应用程序的NLC开发

获取原文

摘要

NLCs are second generation of lipid nanoparticles which have many advantages that make them interesting for topical drugs delivery systems. All-trans retinoic acids (ATRAs) are highly lipophilic and instable in the presence of air, light and heat. In this study, 0.3% ATRAs loaded NLCs were developed by de novo emulsifications, then were reduced to nano-meter range by ultrasonicator. The characterizations of NLCs i.e. size and zeta potential were examined. NLCs with different solid: liquid lipids ratios (2:1, 1:1 and 1:2), were formulated in order to maximize the skin permeation. The results demonstrate the sizes of NLCs were in nano-meter ranges with negative zeta potential. Moreover the results showed that the amount of solid lipids in the formulation affected the skin permeation. The highest ATRAs permeations though shed snake skin could be achieved from the NLCs which lipid matrixs were composed of 2:1 solid: liquid lipids ratios.
机译:NLC是第二代脂质纳米颗粒,其具有许多优点,使其成为局部药物递送系统的有趣。全反式视黄酸(ATRAS)在空气,光和热存在下非常亲脂性和不稳定。在该研究中,通过DE Novo乳化开发了0.3%的ATRAS负载的NLC,然后通过超声波变化为纳米计范围。研究了NLC的特征。对尺寸和Zeta潜力进行了检查。配制出不同固体的NLCS:液体脂质比(2:1,1:1和1:2),以最大化皮肤渗透。结果证明了NLC的尺寸在纳米米范围内具有负Zeta电位。此外,结果表明,制剂中固体脂质的量影响皮肤渗透。尽管脱落蛇皮可以从NLC实现血液基质由2:1固体组成的NLC来实现最高的ATRAS渗透渗透性,所述脂质基质:液体脂质比率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号